Cargando…
Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patients
Patients with chronic kidney disease (CKD) have a high burden of mortality and cardiovascular morbidity. Additional strategies to modulate cardiovascular risk in this population are needed. Anaemia has been associated with adverse outcomes in CKD populations, and the ability to modify this parameter...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638547/ https://www.ncbi.nlm.nih.gov/pubmed/19461857 http://dx.doi.org/10.1093/ndtplus/sfn174 |